Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 5, 2004. The report details changes in directors' interests in the company's Ordinary Shares and American Depository Shares (ADSs) for the quarter ending March 31, 2004, including share allocations and trust transactions.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance disclosures regarding director shareholdings and employee trust movements.
Material Changes
- Non-Executive Director Allocations: Provisional awards of Ordinary Shares and ADSs were allocated to non-executive directors for the period of service from January 1 to March 31, 2004, under automatic and share election arrangements.
- Employee Trust Transfer: On April 1, 2004, the GlaxoSmithKline Employee Trust transferred 6,650 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- US Retirement Plan Movement: The GlaxoSmithKline US Retirement Savings Plan saw a decrease in Ordinary Share ADRs from 18,906,970 to 18,830,189 on April 1, 2004, at an average price of $40.00.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a statutory disclosure of director interests and does not contain forward-looking financial statements.
Investor Verification Checklist
- Verify the total number of shares and ADSs allocated to specific non-executive directors under both automatic and election arrangements.
- Confirm the impact of the 6,650 share transfer from the GSK Trust on the SmithKline Beecham Employee Share Option Plan 1991.
- Review the reduction in the US Retirement Savings Plan holdings (76,781 ADRs) and its valuation at the $40.00 average price.
- Identify which directors hold indirect interests through the GSK Trust and the US Retirement Savings Plan.